TRIP13 and hepatocellular carcinoma: Knocking out OCT4 in HCC-derived cell lines reduced the expression of TK1 and TRIP13 and significantly decreased their tumorigenicity.<h4>Conclusions</h4>Using RNA-seq, we identified several novel HCC signature genes that may serve as biomarkers for its diagnosis and prognosis.